AVEO Pharmaceuticals Company Profile (NASDAQ:AVEO)

About AVEO Pharmaceuticals

AVEO Pharmaceuticals logoAVEO Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's platform delivers insights into cancer and related disease. The Company's product candidates include Tivozanib, Ficlatuzumab, AV-203 and AV-380. Tivozanib is a selective long half-life vascular endothelial growth factor tyrosine kinase inhibitor (VEGF TKI) that inhibits over three VEGF receptors. Tivozanib is designed to optimize VEGF blockade while minimizing off-target toxicities. Ficlatuzumab is a Hepatocyte Growth Factor (HGF) inhibitory antibody. AV-203 is an anti-ErbB3 monoclonal antibody with ErbB3 affinity. Its preclinical studies suggest that neuregulin1 (NRG1) levels predict AV-203 antitumor activity in preclinical models. AV-380 is a humanized Immunoglobulin G 1 (IgG1) inhibitory monoclonal antibody. AV-380 targets growth differentiating factor 15 (GDF15).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: AVEO
  • CUSIP: 05358810
Key Metrics:
  • Previous Close: $0.89
  • 50 Day Moving Average: $0.92
  • 200 Day Moving Average: $0.95
  • 52-Week Range: $0.81 - $1.47
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.07
  • P/E Growth: 0.00
  • Market Cap: $67.51M
  • Outstanding Shares: 75,859,000
  • Beta: 0.65
Profitability:
  • Net Margins: -74.37%
  • Return on Equity: -101.11%
  • Return on Assets: -37.94%
Debt:
  • Debt-to-Equity Ratio: 1.66%
  • Current Ratio: 6.07%
  • Quick Ratio: 6.07%
Additional Links:
Companies Related to AVEO Pharmaceuticals:

Analyst Ratings

Consensus Ratings for AVEO Pharmaceuticals (NASDAQ:AVEO) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $2.35 (164.04% upside)

Analysts' Ratings History for AVEO Pharmaceuticals (NASDAQ:AVEO)
Show:
DateFirmActionRatingPrice TargetDetails
9/13/2016FBR & CoReiterated RatingBuyView Rating Details
6/16/2016Piper Jaffray Cos.Reiterated RatingBuyView Rating Details
3/9/2015Royal Bank Of CanadaUpgradeUnderperform -> Sector Perform$2.00 -> $3.00View Rating Details
(Data available from 10/1/2014 forward)

Earnings

Earnings History for AVEO Pharmaceuticals (NASDAQ:AVEO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
5/10/2016Q1($0.12)($0.13)ViewN/AView Earnings Details
3/15/2016Q415($0.04)($0.11)$3.60 millionViewN/AView Earnings Details
11/9/2015Q315($0.09)$0.14ViewN/AView Earnings Details
8/10/2015Q2($0.16)($0.10)ViewListenView Earnings Details
5/7/2015Q115($0.25)($0.21)ViewN/AView Earnings Details
3/6/2015Q314($0.28)($0.27)ViewListenView Earnings Details
11/5/2014($0.23)($0.28)ViewN/AView Earnings Details
8/11/2014Q214($0.44)($0.35)$1.75 millionViewN/AView Earnings Details
5/7/2014($0.40)($0.12)ViewN/AView Earnings Details
3/13/2014Q413($0.33)($0.32)$0.14 million$0.32 millionViewListenView Earnings Details
11/4/2013Q313($0.47)($0.47)$0.23 million$0.32 millionViewN/AView Earnings Details
8/1/2013Q213($0.56)($0.62)$4.30 million$0.32 millionViewN/AView Earnings Details
4/29/2013Q1 2013($0.72)($0.69)$2.52 million$0.32 millionViewListenView Earnings Details
2/13/2013Q4 2012($0.77)($0.49)$14.49 million$15.53 millionViewN/AView Earnings Details
10/30/2012Q312($0.87)($0.69)$6.57 million$1.02 millionViewN/AView Earnings Details
8/2/2012($0.82)($0.68)ViewN/AView Earnings Details
5/3/2012($0.78)($0.77)ViewN/AView Earnings Details
2/14/2012($0.64)($0.58)ViewN/AView Earnings Details
11/2/2011($0.46)($0.55)ViewN/AView Earnings Details
7/28/2011($0.80)($0.16)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for AVEO Pharmaceuticals (NASDAQ:AVEO)
Current Year EPS Consensus Estimate: $-0.50 EPS
Next Year EPS Consensus Estimate: $-0.43 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.13)($0.13)($0.13)
Q2 20161($0.15)($0.15)($0.15)
Q3 20161($0.18)($0.18)($0.18)
Q4 20161($0.21)($0.21)($0.21)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for AVEO Pharmaceuticals (NASDAQ:AVEO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for AVEO Pharmaceuticals (NASDAQ:AVEO)
Insider Ownership Percentage: 5.10%
Institutional Ownership Percentage: 39.10%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/16/2015Matthew D DallasVPSell3,075$0.82$2,521.50View SEC Filing  
1/7/2015Michael P BaileyCEOSell4,484$0.80$3,587.20View SEC Filing  
1/30/2014Joseph VittiglioSVPSell5,430$1.64$8,905.20View SEC Filing  
3/14/2013David Brannon JohnstonCFOSell1,061$7.34$7,787.74View SEC Filing  
3/7/2013Henri A TermeerDirectorBuy55,499$6.73$373,508.27View SEC Filing  
12/13/2012Ngoc Tuan HaCEOBuy75,000$6.65$498,750.00View SEC Filing  
12/13/2012Robert C YoungDirectorBuy2,371$6.78$16,075.38View SEC Filing  
12/3/2012Robert C YoungDirectorBuy1,250$6.41$8,012.50View SEC Filing  
9/13/2012David Brannon JohnstonCFOSell1,386$10.60$14,691.60View SEC Filing  
8/8/2012Robert C YoungDirectorBuy1,000$8.63$8,630.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for AVEO Pharmaceuticals (NASDAQ:AVEO)
DateHeadline
businesswire.com logoAVEO Oncology Announces Proposed Settlement and Settlement Hearing in 2014 Stockholder Litigation - Business Wire (press release) (NASDAQ:AVEO)
www.businesswire.com - September 30 at 4:06 PM
News IconCatching the Wonder of Investors: AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Duncan Research (NASDAQ:AVEO)
www.duncanindependent.com - September 30 at 4:06 PM
finance.yahoo.com logoAVEO Oncology Announces Proposed Settlement and Settlement Hearing in 2014 Stockholder Litigation (NASDAQ:AVEO)
finance.yahoo.com - September 30 at 4:06 PM
News IconInterested Penny Stock Investors Keen on Shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Duncan Research (NASDAQ:AVEO)
www.duncanindependent.com - September 29 at 3:52 PM
News IconYesterday Stock Price Swings: Intellipharmaceutics International Inc ... - Wall Street Times (press release) (NASDAQ:AVEO)
www.wallstreetnews24.com - September 28 at 3:37 PM
News IconPenny Stock Investors are Growing Curious About AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Duncan Research (NASDAQ:AVEO)
www.duncanindependent.com - September 27 at 3:40 PM
News IconUnder the Microscope: Zeroing in on Shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Duncan Research (NASDAQ:AVEO)
www.duncanindependent.com - September 26 at 3:47 PM
finance.yahoo.com logoAVEO Pharmaceuticals (AVEO) Sees Hammer Chart Pattern: Time to Buy? (NASDAQ:AVEO)
finance.yahoo.com - September 26 at 3:47 PM
News IconKeen Investors Find News on AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Duncan Research (NASDAQ:AVEO)
www.duncanindependent.com - September 23 at 4:04 PM
News IconChart Pattern: What Next for AVEO Pharmaceuticals, Inc. After Forming Bullish Descending Triangle? - Chester News (NASDAQ:AVEO)
www.chesterindependent.com - September 23 at 4:04 PM
investopedia.com logoAVEO Collaborates With Bristol-Myers Squibb for RCC Drug (AVEO, BMY) - Investopedia (NASDAQ:AVEO)
www.investopedia.com - September 23 at 8:41 AM
News IconAnalysts' Consensus Opinions for: BBX Capital Corporation (NYSE:BBX) , AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Wall Street Times (press release) (NASDAQ:AVEO)
www.wallstreetnews24.com - September 23 at 8:41 AM
News IconUnder the Microscope, Zeroing in at AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Duncan Research (NASDAQ:AVEO)
www.duncanindependent.com - September 23 at 8:41 AM
investopedia.com logoAVEO Collaborates With Bristol-Myers Squibb for RCC Drug (AVEO, BMY) (NASDAQ:AVEO)
www.investopedia.com - September 23 at 8:41 AM
News IconStock Seen Gapping Up Pre-Bell: AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Post News (NASDAQ:AVEO)
www.kentuckypostnews.com - September 22 at 3:45 PM
News IconPenny Stock Investors Keen on Shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Duncan Research (NASDAQ:AVEO)
www.duncanindependent.com - September 22 at 3:45 PM
prnewswire.com logoRenal Cell Carcinoma - Global Drugs Market Forecast and Pipeline Analysis to 2021 (NASDAQ:AVEO)
www.prnewswire.com - September 21 at 7:55 AM
sbwire.com logoNew Market Study, "Fibroblast Growth Factor Receptor 4 - Pipeline Review, H2 2016", Has Been Published (NASDAQ:AVEO)
www.sbwire.com - September 19 at 4:34 PM
News IconKeen Investors Seek Information on AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Duncan Research (NASDAQ:AVEO)
www.duncanindependent.com - September 16 at 3:40 PM
kcregister.com logoStock Highlights: AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), MobileIron, Inc. (NASDAQ:MOBL), Connecticut Water ... - KC Register (NASDAQ:AVEO)
www.kcregister.com - September 15 at 8:58 PM
News IconAveo Pharmaceuticals Incorporated (NASDAQ:AVEO) Shorted Shares Increased 85.51% After Market Selling - Post News (NASDAQ:AVEO)
www.kentuckypostnews.com - September 15 at 3:50 PM
News IconWhat Analyst told about: AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) , Heico Corporation (NYSE:HEI) - Wall Street Times (press release) (NASDAQ:AVEO)
www.wallstreetnews24.com - September 15 at 3:50 PM
News IconStock Update, a Closer Look at AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Duncan Research (NASDAQ:AVEO)
www.duncanindependent.com - September 15 at 3:50 PM
News IconKeen Investors Narrowing Their Focus on AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Duncan Research (NASDAQ:AVEO)
www.duncanindependent.com - September 14 at 8:53 PM
News IconPenny Stock Investors Highly Curious in Shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Duncan Research (NASDAQ:AVEO)
www.duncanindependent.com - September 14 at 7:13 AM
reuters.com logoBRIEF-Aveo Pharmaceuticals announced discontinuation of focal study (NASDAQ:AVEO)
www.reuters.com - September 13 at 3:45 PM
kcregister.com logoInvestors Alert: AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), Navidea Biopharmaceuticals, Inc (NYSE:NAVB ... - KC Register (NASDAQ:AVEO)
www.kcregister.com - September 13 at 8:29 AM
kcregister.com logoInvestors Alert: AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO ... - KC Register (NASDAQ:AVEO)
www.kcregister.com - September 12 at 3:37 PM
News IconExpert's Viewpoint for: Core-Mark Holding Company, Inc. (NASDAQ:CORE) , AVEO Pharmaceuticals, Inc. (NASDAQ ... - Wall Street Times (press release) (NASDAQ:AVEO)
www.wallstreetnews24.com - September 12 at 8:27 AM
biz.yahoo.com logoAVEO PHARMACEUTICALS INC Files SEC form 8-K, Other Events (NASDAQ:AVEO)
biz.yahoo.com - September 12 at 8:27 AM
capitalcube.com logoETF’s with exposure to AVEO Pharmaceuticals, Inc. : September 9, 2016 (NASDAQ:AVEO)
www.capitalcube.com - September 9 at 3:38 PM
finance.yahoo.com logoAVEO to Present at the 18th Annual Rodman & Renshaw Global Investment Conference (NASDAQ:AVEO)
finance.yahoo.com - September 6 at 8:28 AM
law360.com logoAveo Promises Reforms In Cancer Drug Derivative Settlement (NASDAQ:AVEO)
www.law360.com - August 27 at 8:28 AM
News IconHave You Received Your Immune Checkpoint Inhibitor Yet? (NASDAQ:AVEO)
www.ascopost.com - August 25 at 3:42 PM
News IconShares Gapping Before the Open: AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Post News (NASDAQ:AVEO)
www.kentuckypostnews.com - August 24 at 3:41 PM
News IconHot Stocks: B&G Foods, Inc.(NYSE:BGS), AVEO Pharmaceuticals, Inc.(NASDAQ:AVEO) - NYSE Journal (press release) (NASDAQ:AVEO)
stockznews.com - August 15 at 3:44 PM
reuters.com logoBRIEF-NeuroVive says completes 10 pct acquisition of Isomerase Therapeutics (NASDAQ:AVEO)
www.reuters.com - August 15 at 10:53 AM
News IconAVEO Initiates the Evaluation of Tivozanib in Combination with Bristol-Myers Squibb’s Opdivo® (nivolumab) in Advanced Rena... (NASDAQ:AVEO)
ih.advfn.com - August 15 at 10:53 AM
finance.yahoo.com logo7:01 am AVEO Oncology initiates a clinical evaluation of tivozanib in combination with Bristol-Myers Squibb's (BMY (NASDAQ:AVEO)
finance.yahoo.com - August 15 at 10:53 AM
publicnow.com logoAVEO Initiates the Evaluation of Tivozanib in Combination with Bristol-Myers Squibb’s Opdivo® (nivolumab) in Advanced Renal Cell Carcinoma (NASDAQ:AVEO)
www.publicnow.com - August 15 at 10:53 AM
finance.yahoo.com logoAVEO PHARMACEUTICALS INC Financials (NASDAQ:AVEO)
finance.yahoo.com - August 13 at 3:40 PM
capitalcube.com logoETF’s with exposure to AVEO Pharmaceuticals, Inc. : August 11, 2016 (NASDAQ:AVEO)
www.capitalcube.com - August 11 at 12:56 PM
bizjournals.com logoColorectal Cancer Pipeline 2016 Global Market Review Covering 227 Companies (NASDAQ:AVEO)
www.bizjournals.com - August 10 at 8:44 AM
capitalcube.com logoAVEO Pharmaceuticals, Inc. :AVEO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NASDAQ:AVEO)
www.capitalcube.com - August 9 at 12:31 PM
finance.yahoo.com logoAVEO (AVEO) Reports a Wider Loss in Q2, Tivozanib in Focus - Yahoo Finance (NASDAQ:AVEO)
finance.yahoo.com - August 5 at 9:02 PM
twst.com logoAVEO Pharmaceuticals Inc.: AVEO Oncology Reports Second ... - The Wall Street Transcript (NASDAQ:AVEO)
www.twst.com - August 4 at 12:10 PM
sg.finance.yahoo.com logoAVEO reports 2Q loss (NASDAQ:AVEO)
sg.finance.yahoo.com - August 4 at 12:10 PM
finance.yahoo.com logoAVEO (AVEO) Reports Narrower-than-Expected Loss in Q2 (NASDAQ:AVEO)
finance.yahoo.com - August 4 at 12:10 PM
finance.yahoo.com logoWill AVEO (AVEO) Pull a Surprise This Earnings Season? (NASDAQ:AVEO)
finance.yahoo.com - August 3 at 9:20 PM
bizjournals.com logoPancreatic Cancer Pipeline 2016 Market Report of 282 Companies (NASDAQ:AVEO)
www.bizjournals.com - August 2 at 8:27 AM

Social

AVEO Pharmaceuticals (NASDAQ:AVEO) Chart for Saturday, October, 1, 2016


Last Updated on 10/1/2016 by MarketBeat.com Staff